ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIOL Biolase Inc

0.176
0.0309 (21.30%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biolase Inc NASDAQ:BIOL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0309 21.30% 0.176 0.1677 0.176 0.1899 0.146 0.15 5,119,362 00:55:37

BIOLASE Schedule Of Investor Conferences For September 2021

08/09/2021 9:05pm

PR Newswire (US)


Biolase (NASDAQ:BIOL)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Biolase Charts.

FOOTHILL RANCH, Calif., Sept. 8, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021:

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.)

Colliers 2021 Institutional Conference
Thursday, September 9 (one-on-one meetings only)

H.C. Wainwright 23rd Annual Global Investment Conference
Thursday, September 13-15th  (formal presentation available September 13th at 7:00 am ET)

BIOLASE president and CEO John Beaver, and Vice President of Finance, Jennifer Bright will be hosting virtual one-on-one meetings with institutional investors at these conferences. For additional information or to schedule a virtual meeting with management, please contact your representative at the firms hosting the conferences, or BIOLASE's investor relations firm, EVC Group (contact info below).

To access a webcast of BIOLASE's presentation at the H.C. Wainwright conference, please visit the investor relations section of BIOLASE's website at www.biolase.com.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-schedule-of-investor-conferences-for-september-2021-301371708.html

SOURCE BIOLASE, Inc.

Copyright 2021 PR Newswire

1 Year Biolase Chart

1 Year Biolase Chart

1 Month Biolase Chart

1 Month Biolase Chart

Your Recent History

Delayed Upgrade Clock